<http://webisa.webdatacommons.org/prov/318770497>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/44191181> .
<http://webisa.webdatacommons.org/44191181>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<globenewswire.com> .
<http://webisa.webdatacommons.org/44191181>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/44191181>	<http://www.w3.org/ns/prov#value>	"We believe this reflects the growth of our therapeutic programs, particularly our proprietary MultiStem product platform and its innovative applications in treating inflammatory and immune disorders, neurological conditions, cardiovascular disease and other conditions, which we continue to advance in clinical trials." .
<http://webisa.webdatacommons.org/prov/351009104>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/44191181> .